This invention relates to 6 alkynyl pyridine of general formula (I) their use as SMAC mimetics pharmaceutical compositions containing them and their as a medicaments for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. The groups Rto R have the meanings given in the claims and in the specification.